4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-062651
Director bought 1,550 shares at an average $2.22 ($3,447)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Galante Joseph C Director | 2022-12-01 | Purchase | +65 | $2.33 | $151 | 55,871 | D |
| Galante Joseph C Director | 2022-12-02 | Purchase | +65 | $2.31 | $150 | 55,936 | D |
| Galante Joseph C Director | 2022-12-05 | Purchase | +65 | $2.19 | $142 | 56,001 | D |
| Galante Joseph C Director | 2022-12-06 | Purchase | +65 | $2.19 | $142 | 56,066 | D |
| Galante Joseph C Director | 2022-12-07 | Purchase | +65 | $2.18 | $142 | 56,131 | D |
| Galante Joseph C Director | 2022-12-08 | Purchase | +65 | $2.19 | $142 | 56,196 | D |
| Galante Joseph C Director | 2022-12-09 | Purchase | +65 | $2.15 | $140 | 56,261 | D |
| Galante Joseph C Director | 2022-12-12 | Purchase | +65 | $2.14 | $139 | 56,326 | D |
| Galante Joseph C Director | 2022-12-13 | Purchase | +120 | $2.18 | $262 | 56,446 | D |
| Galante Joseph C Director | 2022-12-14 | Purchase | +120 | $2.21 | $265 | 56,566 | D |
| Galante Joseph C Director | 2022-12-15 | Purchase | +60 | $2.24 | $134 | 56,626 | D |
| Galante Joseph C Director | 2022-12-16 | Purchase | +100 | $2.22 | $222 | 56,726 | D |
| Galante Joseph C Director | 2022-12-19 | Purchase | +250 | $2.21 | $553 | 56,976 | D |
| Galante Joseph C Director | 2022-12-20 | Purchase | +200 | $2.31 | $462 | 57,176 | D |
| Galante Joseph C Director | 2022-12-21 | Purchase | +180 | $2.22 | $400 | 57,356 | D |
| Open-market purchases · 1,550 sh · avg $2.22 · $3,447 | |||||||
Loading xslF345X03/doc4.xml…